News
AbbVie will invest $195 million in its North Chicago, Illinois, manufacturing plant to expand domestic API production in the ...
Construction on the site will begin in the fall and is expected to be finished by 2027. North Chicago is already home to ...
Steve Grzanich has the business news of the day with the Wintrust Business Minute. Abbott Laboratories spinoff AbbVie will ...
The company’s commitment to its North Chicago, Ill. plant is part of a previously announced $10 billion capital investment ...
AbbVie (ABBV) announced a $195 million investment in its North Chicago manufacturing facility to boost domestic API ...
1d
Pharmaceutical Technology on MSNAbbVie expands North Chicago API production with $195m investment
"AbbVie expands North Chicago API production with $195m investment" was originally created and published by Pharmaceutical ...
The expansion is part of AbbVie’s larger $10 billion commitment to U.S. investment in the face of Trump’s tariff threats.
1d
TipRanks on MSNAbbVie announces $195M investment to expand API manufacturing in U.S.
AbbVie (ABBV) announced a $195M investment in its North Chicago, Illinois manufacturing plant to expand domestic active ...
AbbVie, a global leader in life sciences, announced Tuesday the company’s is investing $195 million to expand its North ...
NORTH CHICAGO Governor JB Pritzker, AbbVie, and the Illinois Department of Commerce and Economic Opportunity (DCEO) today ...
1d
WQRF Rockford on MSNIllinois secures AbbVie’s $195 million investment for North Chicago facility
AbbVie, the maker of Botox, Humira, and Rinvoq, will invest $195 million to expand its North Chicago manufacturing facility, creating at least 50 new jobs within the next three years.
AbbVie will invest $195M to expand API manufacturing at its North Chicago plant, boosting U.S. pharmaceutical innovation, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results